HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
Approved
Approval ID
8879f8d5-e9c6-f749-e053-2a95a90a8af5
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 9, 2019
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2093
Product Classification
G
Generic Name
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.05%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 9, 2019
FDA Product Classification
INGREDIENTS (2)
HYALURONATE SODIUMActive
Quantity: 0.5 g in 100 g
Code: YSE9PPT4TH
Classification: ACTIB
TAZAROTENEActive
Quantity: 0.05 g in 100 g
Code: 81BDR9Y8PS
Classification: ACTIB